Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca Pharma India Ltd. Interim / Quarterly Report 2020

Feb 4, 2020

60656_rns_2020-02-04_209a5760-d6e3-4770-879a-263bd935f77e.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

==> picture [299 x 29] intentionally omitted <==

----- Start of picture text -----

Business Standard BENGALURU I TUESDAY, 4 FEBRUARY 2020
----- End of picture text -----

==> picture [329 x 251] intentionally omitted <==

----- Start of picture text -----

AstraZeneca 4
AstraZeneca Pharma India limited
CIN: L24'231KA1979PLC003563
Regd. Office: Block N1, 12th Floor, Many1ta Emb1uy Business Park,
Rachenahalll, Outer Ring Road, Bangalore • 560 045.
Tel.: +91 80 6774' 8000. Web: www.aatrazeneca.com/lndfa
Statement of unaudited financial results for the quarter and mne months ended 31 Deaimber 2019
RI In lakha ucai,t for oomu lhatl dill
SI. 3 months tnded [Year to ] [date flgura ] [for ] Comspondlng
No. Partlculars 31/1212019 cumnt 31/1212019 period ended 3 the previous y-months ended In
31/1212018
(Unaudited) (Unaudited) (Unaudited)
1 Tolal ITTCOme lrom operatlonS 22 732 43 64.651 87 21,868 97
2 Nel profit/ (loss) for the penod from ordrna,y
acuv111es before tax 3 518 26 10,060 78 4.05946
3 Net profit / (loss) for the penod from ordinary
act,vIbes aner tax 2,670 17 6,26323 2 90918
4 Total comprehen51ve income for Ille penod after tax 2.750 43 6,00010 2 869.72
5 Equity Share Cap!tal 500.00 500 00 50.
6 Reserves (excluding revaluaoon reserves as per
balance sheet)'
7 Basrc and d luled earnings per share (of Rs 2 each) 1068 25.05 1164
Re e,Cludng re aluahon reserves for lheywended 31 Ma!Ch 2019wo11Rs 29.5801akns11 peraudoledfinanaals_, I V "
Note:
----- End of picture text -----

  • 1 The above Is an extract of the deta� formal of Ouarterty F1nanoal Results filed wrth lhe Stock Exchanges under Regula!Jon 33 of lhe SEBI (Llsbng Obligation and Disclosure Requirements) Regulations. 2015 The full formal of the Ooarterty Financial Results is available on the Stock Exchange websites (www nse1nd1a com. www bseInd1a com) and Company's website (www astrazeneca.com/india)

  • 2 The financial results have been prepared In accordance with lhe Companies (lnd1anAccounbng Standards) Rules. 2015 (as amended) presaibed under Section 133 of the Companies Act, 2013 and other recognised aa:ounbng pracbces and po'ICMIS to the extent applicable By Ordtt of tho Boord of D111Ctora For AttraZtneca Ph1nn1 lndl1 Llmlttd

  • Place: Bangalore Gavandffp Singh Bodi Date: 03-02-2020 Managing D,roctor

==> picture [12 x 99] intentionally omitted <==

==> picture [15 x 124] intentionally omitted <==

..

==> picture [596 x 842] intentionally omitted <==

----- Start of picture text -----

, .• ,­
--
. � ...
. .....
....
�VWl-iOZO
.
su o
z..im.rr
- "'"-U
?:: . .
6.26-1$3
tft_'W'r;m;'Md::
&OOtt:W
----- End of picture text -----